DOD Biotech Public Company Limited
DOD Biotech Public Company Limited, together with its subsidiaries, manufactures and distributes dietary supplements in Thailand. It offers dietary supplements for beauty and health in various forms comprising capsules, gels, jellies, powder, shot drinks, soft gels, tablets, probiotics, gummies, and direct-to-mouth. The company also provides food supplements and health drinks. In addition, it off… Read more
Market Cap & Net Worth: DOD Biotech Public Company Limited (DOD)
DOD Biotech Public Company Limited (BK:DOD) has a market capitalization of $24.03 Million (฿833.27 Million) as of March 19, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #27082 globally and #454 in its home market, demonstrating a 3.93% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DOD Biotech Public Company Limited's stock price ฿1.85 by its total outstanding shares 450414285 (450.41 Million).
DOD Biotech Public Company Limited Market Cap History: 2018 to 2026
DOD Biotech Public Company Limited's market capitalization history from 2018 to 2026. Data shows change from $169.04 Million to $24.03 Million (-23.04% CAGR).
DOD Biotech Public Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DOD Biotech Public Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
DOD Biotech Public Company Limited's market cap is 0.03 times its annual revenue
0.14x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $169.04 Million | $666.36 Million | $305.26 Million | 0.25x | 0.55x |
| 2019 | $93.74 Million | $789.92 Million | $86.71 Million | 0.12x | 1.08x |
| 2020 | $114.03 Million | $1.61 Billion | $141.25 Million | 0.07x | 0.81x |
| 2021 | $145.13 Million | $1.02 Billion | $233.10 Million | 0.14x | 0.62x |
| 2022 | $56.50 Million | $537.16 Million | -$345.12 Million | 0.11x | N/A |
| 2023 | $48.06 Million | $678.15 Million | $7.19 Million | 0.07x | 6.69x |
| 2024 | $21.56 Million | $645.38 Million | -$159.33 Million | 0.03x | N/A |
Competitor Companies of DOD by Market Capitalization
Companies near DOD Biotech Public Company Limited in the global market cap rankings as of March 19, 2026.
Key companies related to DOD Biotech Public Company Limited by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #54 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #69 globally with a market cap of $218.85 Billion USD ( CHF200.39 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #435 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #465 globally with a market cap of $45.94 Billion USD ( €44.75 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #54 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #69 | Nestlé S.A. | SW:NESN | $218.85 Billion | CHF77.97 |
| #435 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #465 | Danone SA | PA:BN | $45.94 Billion | €70.78 |
DOD Biotech Public Company Limited Historical Marketcap From 2018 to 2026
Between 2018 and today, DOD Biotech Public Company Limited's market cap moved from $169.04 Million to $ 24.03 Million, with a yearly change of -23.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ฿24.03 Million | +14.20% |
| 2025 | ฿21.04 Million | -2.41% |
| 2024 | ฿21.56 Million | -55.14% |
| 2023 | ฿48.06 Million | -14.93% |
| 2022 | ฿56.50 Million | -61.07% |
| 2021 | ฿145.13 Million | +27.27% |
| 2020 | ฿114.03 Million | +21.64% |
| 2019 | ฿93.74 Million | -44.54% |
| 2018 | ฿169.04 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of DOD Biotech Public Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.03 Million USD |
| MoneyControl | $24.03 Million USD |
| MarketWatch | $24.03 Million USD |
| marketcap.company | $24.03 Million USD |
| Reuters | $24.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.